Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$31.97 - $49.37 $61,222 - $94,543
1,915 Added 0.53%
362,092 $11.8 Million
Q2 2022

Aug 10, 2022

BUY
$35.61 - $76.23 $309,949 - $663,505
8,704 Added 2.48%
360,177 $14.2 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $290,678 - $416,827
5,050 Added 1.46%
351,473 $24.6 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $3.25 Million - $4.51 Million
-44,768 Reduced 11.44%
346,423 $27 Million
Q3 2021

Nov 10, 2021

SELL
$90.24 - $124.05 $232,458 - $319,552
-2,576 Reduced 0.65%
391,191 $37.3 Million
Q2 2021

Aug 11, 2021

SELL
$93.66 - $139.27 $17,046 - $25,347
-182 Reduced 0.05%
393,767 $48.9 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $45.9 Million - $61.1 Million
393,949 New
393,949 $52.2 Million
Q3 2020

Nov 12, 2020

SELL
$72.92 - $102.01 $2.86 Million - $4 Million
-39,183 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$55.75 - $92.75 $53 Million - $88.2 Million
-951,327 Reduced 96.04%
39,183 $3.37 Million
Q1 2020

May 11, 2020

SELL
$37.9 - $104.44 $2.59 Million - $7.13 Million
-68,247 Reduced 6.45%
990,510 $57.4 Million
Q4 2019

Feb 07, 2020

SELL
$77.66 - $99.74 $2.58 Million - $3.32 Million
-33,251 Reduced 3.04%
1,058,757 $97.9 Million
Q3 2019

Nov 04, 2019

SELL
$90.37 - $122.49 $879,028 - $1.19 Million
-9,727 Reduced 0.88%
1,092,008 $98.7 Million
Q2 2019

Aug 05, 2019

BUY
$89.51 - $118.04 $457,575 - $603,420
5,112 Added 0.47%
1,101,735 $130 Million
Q1 2019

May 01, 2019

BUY
$61.98 - $96.5 $6.2 Million - $9.66 Million
100,072 Added 10.04%
1,096,623 $95 Million
Q4 2018

Feb 11, 2019

SELL
$56.04 - $82.66 $13 Million - $19.1 Million
-231,132 Reduced 18.83%
996,551 $62.9 Million
Q3 2018

Nov 08, 2018

BUY
$48.29 - $80.6 $18.8 Million - $31.3 Million
388,434 Added 46.28%
1,227,683 $96.9 Million
Q2 2018

Aug 07, 2018

SELL
$37.84 - $69.96 $35.4 Million - $65.4 Million
-935,301 Reduced 52.71%
839,249 $50.2 Million
Q1 2018

May 09, 2018

SELL
$39.82 - $57.53 $747,700 - $1.08 Million
-18,777 Reduced 1.05%
1,774,550 $71.6 Million
Q4 2017

Feb 09, 2018

SELL
$46.49 - $60.51 $1.86 Million - $2.42 Million
-39,975 Reduced 2.18%
1,793,327 $93.9 Million
Q3 2017

Nov 09, 2017

BUY
$37.05 - $47.12 $67.9 Million - $86.4 Million
1,833,302
1,833,302 $87.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.